PyInvesting

Market research

600739.SHG Liaoning Cheng Da Co., Ltd

SHG CNY Healthcare

Latest close

9.68 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
15B
P/E ratio
9.21
Analyst target
25.69
Dividend yield
1.5%
Beta
0.69

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Liaoning Cheng Da Co., Ltd is currently in a long term downtrend where the price is trading 13.9% below its 200 day moving average.

From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.

Liaoning Cheng Da Co., Ltd's total revenue sank by 13.1% to $4B since the same quarter in the previous year.

Its net income has increased by 437.0% to $2B since the same quarter in the previous year.

Finally, its free cash flow grew by 399.8% to $207M since the same quarter in the previous year.

Based on the above factors, Liaoning Cheng Da Co., Ltd gets an overall score of 3/5.